Search
Last update: : 28.11.2025
Major Research Direction In the Epigenomics of hormone-driven cancers group, current projects focus on The role of 5-hydroxymethylation in cancer Profiling DNA hydroxy-/methylation and…
Last update: : 28.11.2025
PATHWAY-27 The general objective of PATHWAY-27 project addresses the exploitation of bioactive compounds as ingredients of foods that, within the common diet, could significantly benefit human…
Last update: : 28.11.2025
Endocrine therapy to block the estrogen receptor pathway in breast cancer is highly effective, but its usefulness is limited by common intrinsic and acquired resistance. In up to 20% of patients…
Last update: : 28.11.2025
Prostate cancer is the most frequent malignant tumor in males and the second most frequent cause of cancer-related death. Currently, in Germany, more than 60,000 prostate cancers are diagnosed…
Last update: : 28.11.2025
Past Projects PATHWAY-27 project Link to recent publications in breast cancer studies: Oncoimmunology 2017 Oncogene 2017 Oncotarget 2017 Clinical Epigenetics 2021 International Journal of…
Last update: : 28.11.2025
Prostate cancer (PCa) is one of the most common and heterogeneous cancers in men. The clinical course of PCa is highly variable and requires reliable prognostic markers for individualized…
Last update: : 26.11.2025
It has only recently become known that two parallel systems of blood formation exist in the body, originating from different precursor cells. Researchers at the German Cancer Research Center (DKFZ)…
Press releaseLast update: : 25.11.2025
GR 2526 Exploiting the immunopeptidome of experimental glioma Israeli Partner: A. Admon, Technion German Partner: M. Platten, DKFZ Publications No publications available. Ca.-No…
Last update: : 25.11.2025
Ca.-No 170 Mechanisms supporting hepatic ectopic lymphoid-like structures (ELS) development and egression of ELS-resident tumor progenitors Israeli Partner: E. Pikarsky, Hebrew University…
Last update: : 25.11.2025
Ca.-No 176 Dynamic changes in the chromatin-bound p53 interactome in normal and cancer cells Israeli Partner: M. Oren, Weizmann Institute German Partner: J. Krijgsveld,…